QIAGEN OmicSoft and Biomedical Knowledge Base

Using OmicSoft OncoLand to integrate public expression

89 views
March 12, 2025

QIAGEN OmicSoft Lands are high-quality curated repositories of genomics and proteomics data sourced from public, published studies (GEO, EBI, SRA) and consortia (TCGA, CPTAC, GTEx, and more). Because of our expert curation and stringent quality checks, OmicSoft users can deeply investigate across diverse oncology and normal tissue/cell datasets to discover and validate candidate drug targets and biomarkers.

 

In this training, attendees will use OmicSoft Studio, our graphical user interface, to access public data from The Cancer Genome Atlas (TCGA). Using this data, you will learn how to:

• View gene expression and somatic mutation frequency across different tumor types and conditions

• Identify genes whose expression correlates or anti-correlates with mutation of your target

• Prioritize your candidate biomarkers using expression data across comparisons (tumor vs. normal, MUT vs. WT, etc.)

• Establish survival consequences from changes in your candidate biomarker’s expression or mutation status

Related videos

QIAGEN OmicSoft and Biomedical Knowledge Base

Knowledge graphs and more: Analytics-driven drug discovery using advanced biomedical...

2,014 views July 19, 2022

High-quality biomedical relationships knowledge is the cornerstone of modern...

QIAGEN OmicSoft and Biomedical Knowledge Base

Expression data analysis using QIAGEN Omicsoft Studio - Sep 28 2021

887 views October 01, 2021

In this training, users will learn how to generate downstream outputs such...

QIAGEN IPA

Discovery from public oncological data using QIAGEN Omicsoft OncoLand and QIAGEN Ingenuity...

844 views June 18, 2021

In this 90-minute training, we will discuss how to discover and validate...